Hyperglycemia

There are 990 papers on hyperglycemia in aging research: 86 trials and 350 observational studies in people, 245 in animals, 50 in cells, 233 reviews. The newest story, Nov 13, 2026: “Resveratrol reduced kidney scarring in mice with diabetes”.

Disease

990 papers study it661 more mention it206 findings

MeSH

107 new papers in 30 daysSee all 1,651 papers on hyperglycemia

At a glance

Hyperglycemia is associated with cognitive decline in a human observational study and mortality in high-risk and very high-risk older adults with type 2 diabetes. Experiments report increased cellular senescence in vascular endothelial cells under sustained hyperglycemia and in the gingiva of diabetic mice.

206 findings in 170 papers from 1974 to 2026, 30 of them since April 2026

“hyperglycemia (OR 0.23; 95% CI 0.10-0.52) compared to the placebo group (p < 0.05).”
Vitamin D supplementation improves the metabolic syndrome risk profile in postmenopausal womenClimacteric : the journal of the International Menopause Society2019doi:10.1080/13697137.2019.1611761
  • Human trial86
  • Humans350
  • Animals236
  • Model organisms9
  • Cells50
  • In silico14

Interventions

53

Semaglutide

downin humans2downin mice1

3 studies
  1. Semaglutide decreases hyperglycemia in humans.

    “Agonism of the GLP-1 Receptor by semaglutide increased ISR and curbed hyperglycemia.”

    Human trial

    Disruption of Anticipatory Insulin Secretion in Patients with Hyperglycemia and Obesity

    medRxivPreprint

  2. Semaglutide is linked with lower hyperglycemia in a woman with cystic fibrosis and diabetes treated with semaglutide.

    “which over 12 months led to 14.8% total body weight loss and significant glycaemic improvement”

    Humansin a woman with cystic fibrosis and diabetes treated with semaglutide12 monthsfemalesn = 1

    Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon-Like Peptide 1 Agonist: A Case Report

    Respirology case reports

  3. Semaglutide decreases hyperglycemia in high-fat diet-induced obese mice.

    “Semaglutide or CR was capable of ameliorating hyperglycemia and insulin sensitivity”

    Animalsin high-fat diet-induced obese mice40 μg/kgfour weeksmales

    Both subcutaneous semaglutide and calorie restriction improves pancreatic cell hyperplasia and gut microbiota in high-fat diet-induced obese mice

    Nutrition & metabolism

More on Semaglutide

Metformin

downin humans1downin mice1downin reviews1

3 studies
  1. Metformin decreases hyperglycemia in type 2 diabetes.

    “Metformin (dimethyl biguanide) is a primary pharmacotherapy to treat hyperglycemia in type 2 diabetes.”

    Reviewin type 2 diabetes

    Metformin: Antidiabetic actions from cells to tissues

    Metabolism: clinical and experimental

  2. Metformin decreases hyperglycemia in mice (streptozotocin-induced diabetes).

    “both exendin-4 and metformin could effectively alleviate hyperglycemia in diabetic mice”

    Animalsstreptozotocin-induced diabetes

    Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin

    Tissue & cell

  3. Metformin decreases hyperglycemia.

    “Metformin is the safest and the most widely prescribed first-line therapy for managing hyperglycemia due to different underlying causes”

    Review

    Metformin and cognition from the perspectives of sex, age, and disease

    GeroScience

More on Metformin

Caloric restriction

downin rats2downin mice1

3 studies
  1. Caloric restriction decreases hyperglycemia in high-fat diet-induced obese mice.

    “Semaglutide or CR was capable of ameliorating hyperglycemia and insulin sensitivity”

    Animalsin high-fat diet-induced obese micefour weeksmales

    Both subcutaneous semaglutide and calorie restriction improves pancreatic cell hyperplasia and gut microbiota in high-fat diet-induced obese mice

    Nutrition & metabolism

  2. Caloric restriction decreases hyperglycemia in rats (streptozotocin and high-fat diet-induced type 2 diabetes).

    “Glucose tolerance and insulin sensitivity were improved by CR, as well as the levels of fasting and random plasma glucose.”

    Animalsstreptozotocin and high-fat diet-induced type 2 diabetes30% restriction

    Calorie restriction ameliorates hyperglycemia, modulates the disordered gut microbiota, and mitigates metabolic endotoxemia and inflammation in type 2 diabetic rats

    Journal of endocrinological investigation

  3. Caloric restriction decreases hyperglycemia in high-fat diet plus streptozotocin diabetic rats.

    “30% CR significantly attenuated hyperglycemia and dyslipidemia”

    Animalsin high-fat diet plus streptozotocin diabetic rats30% CR regimen30% restriction20 weeksmales

    Protective effects of calorie restriction on insulin resistance and islet function in STZ-induced type 2 diabetes rats

    Nutrition & metabolism

More on Caloric restriction

Resveratrol

downin mice2downin rats1

3 studies
  1. Resveratrol decreases hyperglycemia in mice (high-fat diet plus multiple low-dose streptozotocin-induced diabetes).

    “Treatment with free Res, CS/Res/SeNPs-5, CS/Res/SeNPs-10, and Metformin (Met) improved hyperglycemia, insulin resistance (IR), and dyslipidemia”

    Animalshigh-fat diet plus multiple low-dose streptozotocin-induced diabetesfree

    Biochemical and molecular evaluation of resveratrol and selenium nanoparticles in managing type 2 diabetes and its complications

    Scientific reports

  2. Resveratrol decreases hyperglycemia in rats (streptozotocin-induced diabetes).

    “RSV monotherapy significantly decreased hyperglycemia and other lenticular alterations”

    Animalsstreptozotocin-induced diabetes40 mg/kg/dayeight weeks

    Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract

    Current eye research

  3. Resveratrol decreases hyperglycemia in mice (Sirt1-dependent).

    “as well as other Res-improved metabolic phenotypes including hyperglycemina and hyperlipidemia in mice”

    AnimalsSirt1-dependent

    Resveratrol promotes white adipocytes browning and improves metabolic disorders in Sirt1-dependent manner in mice

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on Resveratrol

SGLT2 inhibitors

downin animals1downin humans1

2 studies
  1. SGLT2 inhibitors decrease hyperglycemia in type 2 diabetes and rodent models.

    “yet ameliorated by SGLT2 inhibitors”

    Animalsin type 2 diabetes and rodent models

    Gut glucose assimilation governs glucose homeostasis through reciprocal interaction between glucose and amino acid transporter

    Cell reports

  2. SGLT2 inhibitors decrease hyperglycemia in humans (adjunctive therapy in T1DM).

    “Agents in the sodium glucose co-transporter-2 inhibitor (SGLT-2) class demonstrate the greatest promise in correcting hyperglycaemia”

    Reviewadjunctive therapy in T1DM

    Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?

    Diabetes therapy : research, treatment and education of diabetes and related disorders

More on SGLT2 inhibitors

Rapamycin

no changein humans1upin mice1

2 studies
  1. Rapamycin increases hyperglycemia in mice (as monotherapy).

    “but exacerbated hyperglycemia, hypertriglyceridemia, and pancreatic islet degranulation”

    Animalsas monotherapymales

    Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice

    Aging cell

  2. Rapamycin showed no clear effect on hyperglycemia in healthy people.

    “No hyperglycemic effects of rapamycin/everolimus have been detected in healthy people.”

    Reviewin healthy people

    Fasting and rapamycin: diabetes versus benevolent glucose intolerance

    Cell death & disease

More on Rapamycin

Fasting-mimicking diet

downin animals1downin mice1

2 studies
  1. Fasting-mimicking diet prevents hyperglycemia during treatment with drugs targeting starvation escape pathways.

    “FMD cycles also prevent hyperglycemia and other toxicities caused by these drugs”

    Animalsduring treatment with drugs targeting starvation escape pathways

    Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape

    Cell metabolism

  2. Fasting-mimicking diet prevents hyperglycemia in HFCD-fed female mice.

    “prevent HFCD-dependent hyperglycaemia, hypercholesterolaemia and hyperleptinaemia”

    Animalsin HFCD-fed female mice2 yearsfemales

    Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan

    Nature metabolism

More on Fasting-mimicking diet

Insulin

downin humans1

1 study
  1. Insulin is linked with lower hyperglycemia in humans (Corticosteroid-associated hyperglycemia).

    “The hyperglycemia was successfully managed with insulin”

    HumansCorticosteroid-associated hyperglycemiamalesn = 1

    Glucocorticoid therapy for acute interstitial nephritis in a patient with diabetic nephropathy: A case report

    Medicine

More on Insulin

Betaine + glycerol + salcaprozate sodium

downin mice1

1 study
  1. Betaine + glycerol + salcaprozate sodium decreases hyperglycemia in mice (obese and diabetic mice).

    “In obese and diabetic mice, BGS effectively suppressed body weight gain and ameliorated hyperglycemia.”

    Animalsobese and diabetic mice

    A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration

    Pharmaceutics

More on Betaine + glycerol + salcaprozate sodium

Propranolol

upin mice1

1 study
  1. Propranolol induces hyperglycemia in mice (chronic migraine model).

    “GLP-1RAs did not affect metabolic parameters, whereas propranolol induced male-specific hyperglycaemia.”

    Animalschronic migraine modelmales

    GLP-1 receptor activation attenuates chronic migraine-like behaviour: Sex-specific modulation of opioid- and endocannabinoid-related pathways

    British journal of pharmacology

More on Propranolol

Reduced carbohydrate diet

downin humans1

1 study
  1. Reduced carbohydrate diet decreases hyperglycemia in humans (hyperglycemic) (-66% (p = 0.021)).

    “In the hyperglycemic participants, the percentage of time spent in hyperglycemia (>10.0 mM) decreased by 50% during the RCHO-early (p = 0.012) and by 66% at RCHO-end (p = 0.021) compared to baseline.”

    Human trialhyperglycemic2 monthsn = 24

    A reduced carbohydrate diet improves glycemic regulation in hyperglycemic older people in a retirement home: the SAGE study

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

More on Reduced carbohydrate diet

Nutritional support

no changein humans1OR 0.97

1 study
  1. Nutritional support showed no clear effect on hyperglycemia in hospitalised patients with diabetes and risk for malnutrition (adjusted OR 0.97, 95% CI 0.56 to 1.67 p=0.90).

    “particularly there was no increase in risk for hyperglycaemia (adjusted OR 0.97, 95% CI 0.56 to 1.67 p=0.90)”

    Human trialin hospitalised patients with diabetes and risk for malnutritionn = 445

    Nutritional support in hospitalised patients with diabetes and risk for malnutrition: a secondary analysis of an investigator-initiated, Swiss, randomised controlled multicentre trial

    BMJ open

More on Nutritional support

Tesamorelin

no changein humans1

1 study
  1. Tesamorelin showed no clear effect on hyperglycemia in humans.

    “Tesamorelin was well-tolerated with a similar frequency of adverse events, including hyperglycemia, between treatment groups.”

    Human trial12-monthn = 38

    Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors

    AIDS (London, England)

More on Tesamorelin

Dexamethasone

no changein humans1

1 study
  1. Dexamethasone showed no clear effect on hyperglycemia in humans (undergoing internal fixation surgery for intertrochanteric fracture).

    “No differences were found in the length of stay, infections, and hyperglycemia between the 2 groups.”

    Human trialundergoing internal fixation surgery for intertrochanteric fractureintravenous10 mgsingle dosen = 160

    The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial

    Surgery

More on Dexamethasone

Clozapine

upin humans1

1 study
  1. Clozapine induces hyperglycemia in humans (refractory dyskinesia in Parkinson's disease).

    “We report the case of a 45-year-old overweight woman with Parkinson's disease who presented with rapid-onset hyperglycaemia within 2 months after starting clozapine for refractory dyskinaesia.”

    Human trialrefractory dyskinesia in Parkinson's disease2 monthsfemales

    Rapid-onset clozapine-induced hyperglycaemia: pathways of glycaemic dysregulation

    BMJ case reports

More on Clozapine

All 53

Effects

30

Cellular senescence

upin reviews3upin mice2upin cells1

6 studies
  1. Hyperglycemia induces cellular senescence (via oxidative stress, mitochondrial dysfunction and NLRP3 inflammasome activation).

    “Hyperglycemia and lipotoxicity induce premature senescence in endothelial cells, vascular smooth muscle cells, and macrophages”

    Reviewvia oxidative stress, mitochondrial dysfunction and NLRP3 inflammasome activation

    Cellular Senescence Drives Diabetic Atherosclerosis: Aging Mechanisms and Integrative Therapeutic Implications

    Aging and disease

  2. Hyperglycemia induces cellular senescence in cells (sustained hyperglycemia in cell culture models).

    “sustained hyperglycemia provoked cellular senescence in subsets of vascular endothelial cells”

    Cellssustained hyperglycemia in cell culture modelsvascular endothelial cells

    Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results

    Nature medicine

  3. Hyperglycemia induces cellular senescence (hyperglycemia).

    “hyperglycemic conditions can induce senescence and dysfunction in both transplanted and resident MSCs”

    Reviewhyperglycemia

    Enhancing the therapeutic efficacy of mesenchymal stem cell transplantation in diabetes: Amelioration of mitochondrial dysfunction-induced senescence

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  4. Hyperglycemia induces cellular senescence.

    “Hyperglycemia, oxidative stress, persistent chronic inflammation, glucose toxicity, advanced glycation end-products (AGEs) accumulation, lipid metabolism disorders, and lipotoxicity contribute to the cellular senescence”

    Reviewtubular epithelial cells

    Cellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease

    Frontiers in endocrinology

  5. Hyperglycemia increases cellular senescence in mice (diabetic mice).

    “hyperglycemia increased the infiltrated macrophage senescence in gingival tissue of diabetic mice”

    Animalsdiabetic micegingiva

    Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation

    The Journal of biological chemistry

  6. Hyperglycemia increases cellular senescence in mice (streptozotocin-induced diabetes).

    “These changes were accompanied by an increase in senescence-associated β-galactosidase staining in tubular epithelial cells.”

    Animalsstreptozotocin-induced diabeteskidney4 weeks after STZ injection

    Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy

    Journal of diabetes and its complications

More on Cellular senescence

Oxidative stress and ROS signaling

upin reviews2upin rats1

3 studies
  1. Hyperglycemia induces oxidative stress and ROS signaling.

    “persistent hyperglycemia triggers excessive oxidative stress”

    Review

    Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review)

    Biomedical reports

  2. Hyperglycemia induces oxidative stress and ROS signaling.

    “including hyperglycemia and hyperlipidemia evoked oxidative stress and inflammation”

    Reviewvascular endothelium

    Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes

    Frontiers in physiology

  3. Hyperglycemia increases oxidative stress and ROS signaling in young dyslipidemic rats.

    “Hyperglycemia onset further augmented OS and inflammatory markers in young dyslipidemic rats significantly (p < 0.05).”

    Animalsin young dyslipidemic rats

    Aging and Hyperglycemia Intensify Dyslipidemia-Induced Oxidative Stress and Inflammation in Rats: Assessment of Restorative Potentials of ALA and EPA + DHA

    Inflammation

More on Oxidative stress and ROS signaling

Senescence-associated secretory phenotype (SASP)

upin mice2upin cells1

2 studies
  1. Hyperglycemia induces senescence-associated secretory phenotype (SASP) in mice.

    “induced the serum secretion of SASP factors in vivo”

    Animals

    Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation

    The Journal of biological chemistry

  2. Hyperglycemia induces senescence-associated secretory phenotype (SASP) in endothelial cells and macrophages in vitro.

    “hyperglycaemic stimulus largely phenocopies the SASP acquired during replicative senescence”

    Cellsin endothelial cells and macrophages in vitro

    Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages

    Redox biology

  3. Hyperglycemia induces senescence-associated secretory phenotype (SASP) in vivo exposure, mouse kidney.

    “an archetypal SASP response that was at least partly attributable to endothelial cells and macrophages is induced in mouse kidney after in vivo exposure to sustained hyperglycaemia”

    Animalsin vivo exposure, mouse kidneykidneyshort-term

    Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages

    Redox biology

More on Senescence-associated secretory phenotype (SASP)

Fractional anisotropy of the anterior corona radiata

downin humans1

1 study
  1. Hyperglycemia is linked with lower fractional anisotropy of the anterior corona radiata in cognitively unimpaired cohort.

    “stepwise reduc tions in fractional anisotropy of the anterior corona radiata across glycemic cat egories (normoglycemia > prediabetes > diabetes) in CU individuals”

    Humansin cognitively unimpaired cohort

    Metabolic dysfunction associates with neuroimaging measures of brain structure and connectivity

    Frontiers in neuroscience

More on Fractional anisotropy of the anterior corona radiata

Matrix mineralization

downin mouse cells1

1 study
  1. Hyperglycemia decreases matrix mineralization in mouse cells (by week 4 of differentiation).

    “only rapamycin rescued hyperglycaemia-impaired mineralisation by week 4”

    Cellsby week 4 of differentiationup to week 4

    Hyperglycaemia impairs mineralisation by disrupting coordination of bone and mTOR pathways during osteocyte differentiation

    Research SquarePreprint

Matrix production

upin mouse cells1

1 study
  1. Hyperglycemia increases matrix production in mouse cells (early phase of differentiation).

    “Hyperglycaemia initially enhanced matrix production but later proved detrimental.”

    Cellsearly phase of differentiation

    Hyperglycaemia impairs mineralisation by disrupting coordination of bone and mTOR pathways during osteocyte differentiation

    Research SquarePreprint

dermal fibroblast senescence

upin reviews1

1 study
  1. Hyperglycemia induces dermal fibroblast senescence (chronic hyperglycemia).

    “chronic hyperglycemia induces advanced glycation end-products (AGEs) and oxidative stress, driving dermal fibroblast senescence”

    Reviewchronic hyperglycemiaskin

    Metabolic and cannabinoid crosstalk between diabetes mellitus and skin aging: molecular pathways, fibroblast senescence, and therapeutic strategies

    Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn

Retinal hypoxia

upin reviews1

1 study
  1. Hyperglycemia induces retinal hypoxia (diabetic conditions).

    “hyperglycemia significantly disrupts oxygen metabolism, leading to retinal hypoxia, which affects all retinal cell types”

    Reviewdiabetic conditionsretina

    Retinal Hypoxia as an Early-Detection Imaging Biomarker for Diabetic Retinopathy

    The American journal of pathology

More on Retinal hypoxia

Proliferation

downin reviews1

1 study
  1. Hyperglycemia impairs proliferation.

    “Chronic hyperglycemia disrupts MSC homeostasis through AGE–RAGE signaling, oxidative stress, and inflammatory pathway activation, leading to impaired proliferation, differentiation, immunomodulation”

    Review

    The stromal cell microenvironment and its effect on cell therapy: a review of the literature

    Brazilian Journal of Development

FABP3

upin mice1

1 study
  1. Hyperglycemia increases FABP3 in leptin-deficient ob/ob, Ins2Akita and high-fat fed mouse models.

    “FABP3 expression was also increased in hyperglycemic mouse models such as leptin-deficient ob/ob, Ins2Akita, and high-fat fed mice, as well as in aged mice.”

    Animalsin leptin-deficient ob/ob, Ins2Akita and high-fat fed mouse modelsskeletal muscle

    High glucose induces FABP3-mediated membrane rigidity via downregulation of SIRT1

    Biochimica et biophysica acta. General subjects

More on FABP3

All 30

Upstream

11

SIRT1

upin animals1downin flies1

2 studies
  1. SIRT1 increases hyperglycemia (loss of glycosylation upon refeeding).

    “Loss of glycosylation discomposes these interactions and enhances stability of SIRT1 even upon refeeding, which causes insulin resistance, hyperglycemia and hepatic-inflammation.”

    Animalsloss of glycosylation upon refeedingliver

    Temporal gating of SIRT1 functions by O-GlcNAcylation prevents hyperglycemia and enables physiological transitions in liver

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. SIRT1 decreases hyperglycemia in flies (shown by loss of sir2).

    “loss of the Drosophila SIRT1 homolog sir2 leads to the age-progressive onset of hyperglycemia, obesity, glucose intolerance, and insulin resistance.”

    Model organismsshown by loss of sir2

    Sir2 Acts through Hepatocyte Nuclear Factor 4 to maintain insulin Signaling and Metabolic Homeostasis in Drosophila

    PLoS genetics

More on SIRT1

Time

upin humans1

1 study
  1. time is linked with higher hyperglycemia in humans (from 34.7% to 40.1%).

    “hyperglycemia from 34.7% to 40.1%, and hypertension from 42.3% to 45.1%.”

    Humans2014-2023

    Age- and sex-specific patterns in the prevalence of metabolic syndrome components in the Republic of Korea, 2014-2023: a repeated cross-sectional study of national health screening statistics

    Osong public health and research perspectives

HK2

downin mice1

1 study
  1. HK2 prevents hyperglycemia in astrocytes.

    “The astrocytic Hk2 deletion mice and amygdala-specific astrocytic Hk2 knockdown mice both display anxiety-like behaviors and hyperglycemia.”

    Animalsin astrocytes

    Amygdala astrocyte senescence drives stress-induced anxiety and hyperglycemia

    Cell metabolism

More on HK2

CYP19A1

downin mice1

1 study
  1. CYP19A1 protects against hyperglycemia in mice (shown by knockout in female C57BL/6 mice).

    “AROM KO mice displayed a higher baseline body weight and hyperglycemia and hyperinsulinemia compared to OVX mice”

    Animalsshown by knockout in female C57BL/6 mice17 weeksfemales

    Congenital vs adult-onset estrogen deficiency in female mice: physiological effects and implications for therapy

    The Journal of endocrinology

More on CYP19A1

Psychological resilience

no changein humans1

1 study
  1. Psychological resilience was not clearly linked with hyperglycemia in humans (PLWS and NCs).

    “bidirectional 1-year cross-lagged effects of resilience with physical well-being and obesity, but not with hyperglycemia.”

    HumansPLWS and NCs1 year

    Trajectories of Resilience-Related Traits and Their Impact on Health Outcomes in Schizophrenia: Results From a 4-Year Longitudinal Study

    Schizophrenia bulletin

GHSR

upin mice1

1 study
  1. GHSR increases hyperglycemia in mice (Shown by beta-cell-specific Ghsr deletion in streptozocin-treated mice).

    “We found that middle-aged and old Ghsr-βKO mice were protected from STZ-induced hyperglycemia and impaired insulin secretion”

    AnimalsShown by beta-cell-specific Ghsr deletion in streptozocin-treated micemales

    GHSR Deletion in β-Cells of Male Mice: Ineffective in Obesity, but Effective in Protecting against Streptozotocin-Induced β-Cell Injury in Aging

    Nutrients

More on GHSR

FOXO6

upin rats1

1 study
  1. FOXO6 increases hyperglycemia in rats (high-fat diet).

    “FoxO6 triggered ApoC3-driven lipid accumulation in the livers of aged rats on an HFD and in FoxO6-Tg, consequently leading to hepatic steatosis and hyperglycemia.”

    Animalshigh-fat diet

    FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet

    Aging

More on FOXO6

HVCN1

downin mice1

1 study
  1. HVCN1 protects against hyperglycemia in mice (shown by knockout).

    “Hv1-deficient mice displayed hyperglycemia and glucose intolerance because of reduced insulin secretion”

    Animalsshown by knockout

    Loss of the voltage-gated proton channel Hv1 decreases insulin secretion and leads to hyperglycemia and glucose intolerance in mice

    The Journal of biological chemistry

More on HVCN1

Liver and pancreas fat

downin humans1

1 study
  1. liver and pancreas fat decreases hyperglycemia in humans (removal by substantial weight loss).

    “The consequent hyperglycaemia can be returned to normal by removing the excess fat from liver and pancreas.”

    Reviewremoval by substantial weight lossliver and pancreas

    Calorie restriction for long-term remission of type 2 diabetes

    Clinical medicine (London, England)

Vitamin D deficiency

no changein humans1

1 study
  1. Vitamin D deficiency was not clearly linked with hyperglycemia in humans (Endurance athletes).

    “Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls)”

    HumansEndurance athletes3 yearsn = 47

    Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls)

    PloS one

More on Vitamin D deficiency

All 11

Associations

83

Dementia

upin humans3HR 1.45–2.11

3 studies
  1. Hyperglycemia is linked with a higher risk of dementia in humans (DALYs +3,907,314 (EAPC 2.14), deaths +218,561 (EAPC 2.31)).

    “From 1990 to 2021, the dementia burden attributable to hyperglycemia increased, with DALYs rising by 3,907,314 (EAPC,2.14), deaths by 218,561 (EAPC,2.31)”

    Humans

    Alzheimer's and Other Dementias Attributable to Hyperglycaemia and High BMI Worldwide, 1990-2021: GBD 2021 Cross-sectional Analysis and ARIMA Forecasts

    International journal of surgery (London, England)

  2. Hyperglycemia is linked with a higher risk of dementia in humans (type 1 diabetes) (HR 2.11, 95% CI 1.24, 3.59).

    “those with hyperglycemic events had >2 times the risk (HR 2.11, 95% CI 1.24, 3.59) than those without a hyperglycemic event”

    Humanstype 1 diabetes

    Association of Type 1 Diabetes and Hypoglycemic and Hyperglycemic Events and Risk of Dementia

    Neurology

  3. Hyperglycemia is linked with a higher risk of dementia in humans (fasting glucose ≥7.0 mmol/L) (HR 1.45 [1.03-2.06]).

    “HRs of 1.25 [1.05-1.49] and 1.45 [1.03-2.06] for impaired (5.6-6.9 mmol/L) and hyperglycemic (≥7.0 mmol/L) glucose levels, respectively.”

    Humansfasting glucose ≥7.0 mmol/Lfemales

    Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study

    Medicine

More on Dementia

Older age

upin humans2

2 studies
  1. Older age is associated with hyperglycemia in humans (Receiving dolutegravir-based antiretroviral therapy) (aHR 1.70 per 10 years, 95% CI 1.33–2.18).

    “Higher hazard was associated with older age (per 10 years: aHR 1.70, 95% CI 1.33-2.18)”

    HumansReceiving dolutegravir-based antiretroviral therapyn = 8,856

    Incidence and Predictors of Hyperglycemia Among Adults Receiving Dolutegravir-Based Antiretroviral Therapy at Mbarara Regional Referral Hospital HIV Clinic, Uganda: A Retrospective Cohort Study

    HIV/AIDS (Auckland, N.Z.)

  2. older age is linked with a higher risk of hyperglycemia in humans.

    “Older age and higher adiposity were associated with higher odds”

    Humansfemalesn = 688,349

    Socioeconomic, demographic and anthropometric predictors and geographic variation of screen-detected hyperglycaemia among women in India

    Discover Social Science and Health

Age

upin humans2

2 studies
  1. Age is associated with hyperglycemia in humans.

    “Prevalence generally increased across older age groups, particularly for hypertension and hyperglycemia.”

    Humans

    Age- and sex-specific patterns in the prevalence of metabolic syndrome components in the Republic of Korea, 2014-2023: a repeated cross-sectional study of national health screening statistics

    Osong public health and research perspectives

  2. age is linked with a higher risk of hyperglycemia in humans (adult Lebanese population) (58.5% in elderly vs 46.3% in older adults vs 33.0% in younger adults).

    “Hyperglycaemia significantly increased with age, and was detected in elderly (58.5%), older adults (46.3%) and younger adults (33.0%), p < 0.0001.”

    Humansadult Lebanese populationn = 10,448

    Prevalence of hyperglycaemia, prediabetes and type-2 diabetes mellitus in the adult Lebanese population: results of the PREDICT study

    BMC public health

Pancreatic cancer

upin humans2RR 1.55

2 studies
  1. Hyperglycemia is associated with pancreatic cancer in 2023 in China, higher attributable burden than smoking.

    “In 2023, high fasting plasma glucose (HFPG) accounted for a higher attributable burden than smoking.”

    Humansin 2023 in China, higher attributable burden than smoking

    Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023

    Frontiers in endocrinology

  2. Hyperglycemia raises the risk of pancreatic cancer in humans (RR = 1.55, 95% CI: 1.42-1.70).

    “Hyperglycaemia showed the strongest component-level association (RR = 1.55, 95% CI: 1.42-1.70)”

    Review

    Metabolic Dysfunction and Related Dietary Exposures in Relation to Pancreatic Cancer Risk: A Review of the Evidence

    International journal of molecular sciences

More on Pancreatic cancer

Obesity

upin humans1downin humans1OR 4.67

2 studies
  1. Obesity is linked with a higher risk of hyperglycemia in humans (OR 4.67, 95% CI 1.33-6.37, p = 0.01).

    “to 4.67 times in those with obesity (95% CI 1.33, 6.37, p = 0.01).”

    Humansn = 1,313

    Prevalence of hyperinsulinemia and its association with measures of adiposity and body composition in 16-25-year-old adolescents and young adults in Mumbai

    BMC endocrine disorders

  2. Obesity is associated with hyperglycemia in humans.

    “Logistic regression analysis revealed an age-dependent decline in the association between obesity and hyperglycemia, relative to that in reference-weight individuals.”

    Humansn = 78,776

    Prevalent hyperglycemia in older obese population and age-dependent convergence of obese indices: Results of a cross-sectional study of Japanese generations over the adult life span

    Endocrine research

More on Obesity

Vascular dementia

upin humans2HR 2.373

2 studies
  1. Hyperglycemia predicts vascular dementia in humans (Patients with acute ischemic stroke following intravenous thrombolytic therapy).

    “Multivariate logistic regression identified smoking history, coronary artery disease, hyperglycemia, elevated Systemic Immune-Inflammation Index, increased platelet-to-lymphocyte ratio, lipoprotein, D-dimer, large-vessel stenosis, and strategic infarct location as independent predictors.”

    HumansPatients with acute ischemic stroke following intravenous thrombolytic therapyn = 219

    Analysis of risk factors for vascular dementia following thrombolytic therapy in patients with acute ischemic stroke

    Medicine

  2. Hyperglycemia is associated with vascular dementia in humans (HR 2.373; P < 0.001).

    “central obesity, hyperglycemia, and low high-density lipoprotein (HDL) levels each contributed to an elevated risk of VaD”

    Humans

    Inflammation mediates the association between metabolic syndrome and vascular dementia: A large prospective cohort study

    Atherosclerosis

More on Vascular dementia

Continuous glucose monitoring

upin humans1downin humans1HR 0.88–1.78

2 studies
  1. Continuous glucose monitoring is linked with a higher risk of hyperglycemia in older adults with type 1 diabetes and cognitive impairment/ADRD (HR 1.78 (95% CI 1.15-2.75)).

    “and higher hyperglycemia risk in CGM users with type 1 diabetes (HR: 1.78, 95% CI: 1.15-2.75).”

    Humansin older adults with type 1 diabetes and cognitive impairment/ADRD

    Continuous Glucose Monitoring and Associated Outcomes in Insulin-Using Older Adults with Diabetes and Alzheimer’s Disease and Related Dementias Using Medicare 2016–2020 Data

    ADA Scientific Sessions 2025 abstract

  2. Continuous glucose monitoring is linked with a lower risk of hyperglycemia in humans (type 2 diabetes receiving insulin) (HR 0.88 (95% CI 0.81-0.95)).

    “and admissions for hyperglycemia (0.88: 0.81, 0.95)”

    Humanstype 2 diabetes receiving insulin18 monthsmale (94%)s

    Initiation of Continuous Glucose Monitoring and Mortality in Type 2 Diabetes

    Diabetes technology & therapeutics

More on Continuous glucose monitoring

Incident cardiovascular disease

upin humans1HR 1.21

1 study
  1. Hyperglycemia is associated with incident cardiovascular disease in humans (Korean adults; mutually adjusted associations) (HR 1.21, 95% CI 1.10–1.34).

    “1.19 (1.07–1.32) for abdominal obesity, and 1.21 (1.10–1.34) for hyperglycemia.”

    HumansKorean adults; mutually adjusted associationsn = 179,941

    Metabolic risk factors and incident cardiovascular disease in Korean adults: a pooled analysis of three prospective cohorts

    Nutrition & metabolism

More on Incident cardiovascular disease

Moderate appendicular lean mass

downin humans1OR 0.39

1 study
  1. Moderate appendicular lean mass is associated with hyperglycemia in humans (Moderate visceral adipose tissue; compared with low appendicular lean mass) (OR 0.39, 95% CI 0.16-0.94).

    “with concurrent moderate VAT and moderate ALM (OR 0.39, 95% CI 0.16-0.94), compared to low ALM.”

    HumansModerate visceral adipose tissue; compared with low appendicular lean mass

    Associations between visceral adiposity and cardiometabolic risk indicators vary across skeletal muscle levels: The Tromso Study 2015-2016

    Nutrition, metabolism, and cardiovascular diseases : NMCD

High appendicular lean mass

downin humans1OR 0.1

1 study
  1. High appendicular lean mass is associated with hyperglycemia in humans (High visceral adipose tissue; compared with low appendicular lean mass) (OR 0.10, 95% CI 0.01-0.73).

    “lower likelihood of hyperglycaemia only in participants with concurrent high VAT and high ALM (OR 0.10, 95% CI 0.01-0.73)”

    HumansHigh visceral adipose tissue; compared with low appendicular lean mass

    Associations between visceral adiposity and cardiometabolic risk indicators vary across skeletal muscle levels: The Tromso Study 2015-2016

    Nutrition, metabolism, and cardiovascular diseases : NMCD

2-hour oral glucose tolerance test

upin humans1

1 study
  1. 2-hour oral glucose tolerance test predicts hyperglycemia in humans (high-risk individuals for type 2 diabetes) (AUC=0.981).

    “ROC analysis demonstrated that FVBG (AUC=0.850) and OGTT2h (AUC=0.981) were highly effective diagnostic tools, whereas FFG alone (AUC=0.666) showed limited value.”

    Human trialhigh-risk individuals for type 2 diabetesn = 321

    From biochemical screening to psychosocial intervention: the role of community-based fasting plasma glucose and OGTT in managing health anxiety and uncertainty in high-risk populations

    Psycho-Oncologie

More on 2-hour oral glucose tolerance test

GLP-1 receptor agonists

downin humans1OR 0.69

1 study
  1. GLP-1 receptor agonists lower the risk of hyperglycemia in humans (adjunctive to insulin in type 1 diabetes with overweight or obesity) (OR 0.69 (95% CI 0.55 to 0.86)).

    “while hyperglycaemic episodes decreased (OR: 0.69, 95% CI: 0.55 to 0.86)”

    Human trialadjunctive to insulin in type 1 diabetes with overweight or obesity

    Glucometabolic Outcomes in Patients with Concurrent Overweight/Obesity and Type 1 Diabetes following Prolonged Glucagon-Like Peptide 1 Receptor Agonist Treatment—A Systematic Review and Meta-analysis

    ADA Scientific Sessions 2025 abstract

More on GLP-1 receptor agonists

Cholecalciferol

downin humans1OR 0.23

1 study
  1. Cholecalciferol lowers the risk of hyperglycemia in humans (OR 0.23, 95% CI 0.10-0.52).

    “hyperglycemia (OR 0.23; 95% CI 0.10-0.52) compared to the placebo group (p < 0.05).”

    Human trialvitamin D31000 IU/day9 monthsfemalesn = 160

    Vitamin D supplementation improves the metabolic syndrome risk profile in postmenopausal women

    Climacteric : the journal of the International Menopause Society

More on Cholecalciferol

All 83

Trial sponsors

Funding

19 grants since 2017

National Institute of Diabetes and Digestive and Kidney Diseases$4.9MNational Heart, Lung, and Blood Institute$12.6MNational Institute on Aging$2.9M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate hyperglycemia with cognitive decline, dementia in women and people with type 1 diabetes, and mortality in high- and very-high-risk older adults with type 2 diabetes. A human trial reports reduced hyperglycemia with a reduced-carbohydrate diet in hyperglycemic participants; rapamycin increases hyperglycemia in mice with type 2 diabetes and obese rats.

  2. Summary rewritten as its findings changed.

    As it read before

    A human study links phlegm-dampness, damp-heat, yang-deficient, qi stagnation and blood stasis constitutions to higher hyperglycemia risk. A human preprint links a traditional cereal–vegetable–meat dietary pattern to lower risk, while another human study reports age associations and rising prevalence over time.

  3. Summary written from the findings.

Latest

Dec 2025: 45Jan 2026: 70Feb 2026: 75Mar 2026: 81Apr 2026: 22May 2026: 27Jun 2026: 46Jul 2026: 38Aug 2026: 49Sep 2026: 36Oct 2026: 87Nov 2026: 26602 papers in 12 months
Communications Biology

Resveratrol reduced kidney scarring in mice with diabetes

In experiments in diabetic mice, resveratrol also reduced senescence, a state in which cells stop dividing.In experiments in diabetic mice, resveratrol also reduced senescence, a state in which cells stop dividing.

Mouse studyResveratrol
Infection and Immunity

High blood sugar weakened skin antifungal defenses in mice

Blocking a fungal-sensing protein improved antifungal defenses in experiments with mice that had high blood sugar.Blocking a fungal-sensing protein improved antifungal defenses in experiments with mice that had high blood sugar.

Mouse studySkin

See all 1,651 papers on hyperglycemia